Manufacturer
105 recalls in our database name Lowlite Investments, Inc. D/B/A Olympia Pharmacy as the manufacturing or recalling firm.
Of the 105 recalls from Lowlite Investments, Inc. D/B/A Olympia Pharmacy we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 97 (92%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Olympia Pharmacy is recalling one unit of compounded BNP/dexamethasone eye ointment because FDA inspection findings raised concerns about sterility assurance and quality control. The listed distribution is nationwide and Puerto Rico.
Olympia Pharmacy is recalling two vials of compounded Deslorelin 15 mg due to FDA inspection findings regarding quality control and lack of assurance of sterility.
Olympia Pharmacy is recalling Caco/Copper 6.2 mg/ml Injection because FDA inspection findings raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling three lots of Quadmix because FDA inspections raised concerns about quality control and sterility assurance.
Olympia Pharmacy is recalling 24 units of compounded Trimix nationwide and in Puerto Rico due to FDA inspection findings regarding quality control and sterility assurance.